An audit to identify factors that are more commonly associated with depressed patients on augmentation therapy under the Befordshire East Community Mental Health Team (BECMHT).
BACKGROUND
whilst it is important that we treat patients with depression in primary care if possible there are many patients with depression who will need the more expert support provided in secondary care.


OBJECTIVE
an Anonymised Database held by the Bedford East Community Mental Health Team was studied to assess what factors were related to the use of Augmentation Strategies to treat resistant depression.


RESULTS
of the total 282 patients 109 (38.7%) were on augmentation therapy. In the F32 and F33 group just over a third of the patients (35.8% and 37.1%) were on augmentation therapy and in the F41.2 group over a half of patients (56.7%) were on augmentation therapy.


CONCLUSIONS
There does seem to be a relationship between the number of risk factors a patient has and the likelihood that they are on augmentation. Particularly strong factors are another psychiatric diagnosis and 'other suicide risk factors'.


CONCLUSIONS
generally the patients coming to secondary care with more of the specified risk factors are more likely to need augmentation.
Foundation Programme East Anglian Deanery, UK.
Sophie
S
Butler
Mark
M
Agius
Clare
C
Holt
Rashid
R
Zaman
D000927:Anticonvulsants / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000188:drug therapy; D015897:Comorbidity; D003866:Depressive Disorder / Q000188:drug therapy*; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D004739:England; D006801:Humans; D008485:Medical Audit; D009313:National Health Programs; D012008:Recurrence; D012307:Risk Factors; D059020:Suicidal Ideation; D013406:Suicide, Attempted / Q000517:prevention & control / Q000523:psychology
D000927:Anticonvulsants; D000928:Antidepressive Agents; D014150:Antipsychotic Agents